Angiotensin-converting enzyme inhibition reduces the effect of bromoethylamine-induced papillary necrosis and renal fibrosis

Journal of the American Society of Nephrology

Volumn 9, Issue 6, 1998, Pages 1052-1059

  Garber, Sandra L ^a,c   Mirochnik, Yelena ^b   Desai, Sapan S ^b   Arruda, Jose A L ^a,c,d   Dunea, George ^a,b,c  

^a MA   (United States)

^b HEKTOEN INSTITUTE OF MEDICINE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 BROMOETHYLAMINE; ALBUMIN; ALPHA ACTIN; ANGIOTENSIN; BRADYKININ; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; NITROGEN; TRANSFORMING GROWTH FACTOR BETA1; UREA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; ENZYME INHIBITION; GLOMERULUS FILTRATION RATE; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; KIDNEY PAPILLA NECROSIS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0031798882     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Griffin MD, Bergstralhn EJ, Larson TS: Renal papillary necrosis: A sixteen year clinical experience. J Am Soc Nephrol 6: 248-256, 1995
2. Arruda JAL, Sabatini S, Mehta PK, Sodhi B, Baranowski R: Functional characterization of drug-induced experimental papillary necrosis. Kidney Int 15: 264-275, 1979
3. Murray C, Wyllie RG, Hill GS, Ramsden PW, Heptinstall RH: Experimental papillary necrosis of the kidney. 1. Morphologic and functional data. Am J Pathol 67: 285-302, 1972
4. Bach PH, Gregg NJ: Experimentally induced renal papillary necrosis and upper urothelial carcinoma. Int Rev Exp Pathol 30: 1-54, 1988
5. Klahr S, Ishidoya S, Morrissey J: Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. Am J Kidney Dis 26: 141-146, 1995
6. Pichler RH, Franceschini N, Young BA, Hugo C, Andoh TF, Burdmann EA, Shankland SJ, Alpers CE, Bennett WM, Couser WG, Johnson RJ: Pathogenesis of cyclosporine nephropathy: Roles of angiotensin 11 and osteopontin. J Am Soc Nephrol 6: 1186-1196, 1995
7. Ruiz-Ortega M, Gonzalez S, Seron D, Condom E, Bustos C, Largo R, Gonzalez E, Ortiz A, Egido J: ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int 48: 1778-1791, 1995
8. Uemasu J, Fujiwara M, Munemura C, Kawasaki H: Long-term effects of enalapril in rat with experimental chronic tubulo-interstitial nephropathy. Am J Nephrol 13: 35-42, 1993
9. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D: Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int 32: 78-83, 1987
10. Bedogna V, Valvo E, Casagrunda P, Braggio P, Fontanarosa C, Dal Santo F, Alberti D, Maschio G: Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function. Kidney Int 38: 101-107, 1990
11. Elving LD, Wetzels JF, de Nobel E, Hoitsma AJ, Berden JH: Captopril acutely lowers albuminuria in normotensive patients with diabetic nephropathy. Am J Kidney Dis 20: 559-563, 1992
12. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 85: 541-549, 1990
13. Klahr S, Levey AS, Beck G, Caggiula AW, Hunsicker L, Kusek JW, Striker G: The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 330: 877-884, 1994
14. Hansen HP, Rossing P, Tarnow L, Nielsen FS, Jensen B, Parving HH: Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. Kidney Int 47: 1726-1731, 1995
15. Apperloo AJ, de Zeeuw D, de Jong PE: A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function. Kidney Int 51: 793-797, 1997
16. Ishidoya S, Morrissey J, McCracken R, Klahr S: Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int 49: 1110-1119, 1996
17. Kukinuma Y, Kawamura T, Bills T, Yoshioka T, Ichikawa I, Fogo A: Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int 42: 46-55, 1992
18. 1 and matrix proteins in cyclosporin nephropathy. Kidney Int 52: 660-673, 1997
19. Peters H, Noble NA: Angiotensin II and L-arginine in tissue fibrosis: More than blood pressure. Kidney Int 51: 1481-1486, 1997
20. Eddy AA, Giachelli CM, MeCulloch L, Liu E: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 47: 1546-1557, 1995
21. 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 44: 313-321, 1993
22. Pimentel JL Jr, Sundell CL, Wang S, Kopp JB, Montero A, Martinez-Maldonado M: Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy. Kidney Int 48: 1233-1246, 1995
23. Sharma K, Ziyadeh FN: The emerging role of transforming growth factor-β in kidney disease. Am J Physiol 266: F829-F842, 1994
24. Ketteler M, Noble NA, Border WA: Transforming growth factor-β and the kidney. J Nephrol 8: 143-147, 1995
25. Kagami S, Border WA, Miller DE, Nobel NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93: 2431-2437, 1994
26. Mombouli J-V, Vanhoutte PM: Heterogeneity of endothelium-dependent vasodilator effects of angiotensin-converting enzyme inhibitors: Role of bradykinin generation during ACE inhibition. J Cardiovasc Pharmacol 20: S74-S83, 1992
27. Linz W, Maratorana PA, Scholkens BA: Local inhibition of bradykinin degradation in ischemic hearts. J Cardiovasc Pharmacol 15: S99-S109, 1990
28. Morrissey JJ, Ishidoya S, McCracken R, Klahr S: Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol 7: 2202-2221, 1996